Ornithine and Megestrol acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ornithine (ornithine) and Megestrol acetate (megestrol acetate). Common drug interactions include neutropenia among females and aspartate aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Ornithine and Megestrol acetate. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Ornithine?

Ornithine has active ingredients of ornithine. eHealthMe is studying from 591 Ornithine users. Check the latest studies of Ornithine.

What is Megestrol acetate?

Megestrol acetate has active ingredients of megestrol acetate. It is often used in appetite - decreased. eHealthMe is studying from 5,427 Megestrol acetate users. Check the latest studies of Megestrol acetate.

On Jul, 10, 2026

20 people who take Ornithine and Megestrol acetate together, and have interactions are studied.

Ornithine and Megestrol acetate drug interactions.

What are the common drug interactions of Ornithine and Megestrol Acetate, by gender? *:

female:

Neutropenia (an abnormally low number of neutrophils)
Febrile neutropenia (fever with reduced white blood cells)
Neuropathy peripheral (surface nerve damage)
Peripheral sensory neuropathy (damage to one or more of your peripheral nerves)

male:

Aspartate aminotransferase increased
Diarrhoea
Pleural effusion (water on the lungs)
Renal failure (kidney dysfunction)
Hepatic failure (liver failure)
Hypokalaemia (low potassium)
Liver carcinoma ruptured (ruptured liver cancer tumour)
Dehydration (dryness resulting from the removal of water)
Hyperglycaemia (high blood sugar)
Abdominal pain

What are the common drug interactions of Ornithine and Megestrol Acetate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Aspartate aminotransferase increased
Diarrhoea
Hepatic failure (liver failure)
Hypokalaemia (low potassium)
Liver carcinoma ruptured (ruptured liver cancer tumour)
Abdominal pain

50-59:

Neutropenia (an abnormally low number of neutrophils)
Febrile neutropenia (fever with reduced white blood cells)

60+:

Dehydration (dryness resulting from the removal of water)
Hyperglycaemia (high blood sugar)
Urinary tract infection
Death
Pleural effusion (water on the lungs)
Neuropathy peripheral (surface nerve damage)
Peripheral sensory neuropathy (damage to one or more of your peripheral nerves)
Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

Aspartate Aminotransferase Increased: 9 people, 45.00%
Hepatic Failure (liver failure): 8 people, 40.00%
Headache (pain in head): 8 people, 40.00%
High Blood Pressure: 6 people, 30.00%
Febrile Neutropenia (fever with reduced white blood cells): 5 people, 25.00%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 5 people, 25.00%
Hypokalemia (low potassium): 5 people, 25.00%
Alanine Aminotransferase Increased: 5 people, 25.00%
Diarrhea: 4 people, 20.00%
Essential Hypertension (primary hypertension): 4 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ornithine and Megestrol acetate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously